Geoffrey Beran Rose - 02 Dec 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Lauren Cristina, Attorney-in-Fact
Issuer symbol
LUNG
Transactions as of
02 Dec 2024
Net transactions value
-$27,065
Form type
4
Filing time
04 Dec 2024, 18:18:42 UTC
Previous filing
05 Sep 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $2,426 -392 -0.13% $6.19 295,041 02 Dec 2024 Direct F1
transaction LUNG Common Stock Sale $4,264 -690 -0.23% $6.18 294,351 02 Dec 2024 Direct F2
transaction LUNG Common Stock Sale $10,870 -1,756 -0.6% $6.19 292,595 02 Dec 2024 Direct F3
transaction LUNG Common Stock Sale $9,505 -1,538 -0.53% $6.18 291,057 02 Dec 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.